Drug Database
Back to search

Ireland· IE-PA-EU/1/13/845/009-014

Imatinib Accord 400 mg film-coated tablets

A other antineoplastic agents product containing imatinib mesilate, registered in Ireland by Accord Healthcare S.L.U.. The same ATC class is registered in 5 of our 19 countries.

ATC L01X

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedImatinib Accord 400 mg film-coated ta…ATCL01XREGISTER NO.IE-PA-EU/1/13/845/009…PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about imatinib mesilateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Imatinib mesilate is registered in 5 of 19 countries.

Countries holding a registration under ATC L01X (other antineoplastic agents), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose
Search imatinib mesilate products by name

Imatinib mesilate · ATC L01X

5 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Imatinib mesilate
Manufacturer
Accord Healthcare S.L.U.
Country
Ireland (IE)
ATC code
L01X
ATC class
OTHER ANTINEOPLASTIC AGENTS
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/13/845/009-014

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Imatinib mesilate in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All imatinib mesilate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Imagerolan, Imatinib 1a Pharma
  • Belgium · Imatinib Eg, Imatinib Grindeks
  • Bulgaria · Иматиниб Тева Фарма, Меаксин
  • Cyprus · Imarem, Imatinib Koanaa 100 Mg
  • Czechia · Imanivec, Imatinib Grindeks
  • Germany · Imanivec, Imatinib 1 A Pharma
  • Denmark · Bimatix, Imatinib "sandoz"
  • Estonia · Glipox, Imatinib Grindeks
  • Spain · Imatinib Cipla, Imatinib Farmalider
  • Finland · Bimatix, Imatinib Hexal
  • France · Imatinib Arrow Lab, Imatinib Bgr
  • United Kingdom (Northern Ireland) · Imatinib, Imatinib Amarox
  • Greece · Imatek, Imatinib Aenorasis
  • Croatia · Imakrebin, Meaxin
  • Hungary · Imaniver, Imatinib 1 A Pharma
  • Iceland · Bimatix, Glivec
  • Italy · Imanivec, Imatinib Dr. Reddy’s
  • Liechtenstein · Glivec, Imatinib Accord
  • Lithuania · Glipox, Imatinib Grindeks
  • Luxembourg · Imatinib, Imatinib Eg
  • Latvia · Imatinib Grindeks, Imatinib Inteli
  • Malta · Imatinib Tad, Nibix
  • Netherlands · Bimatix, Imakrebin
  • Norway · Bimatix, Glivec
  • Poland · Imatenil, Meaxin
  • Portugal · Imatinib Aurobindo, Imatinib Aurovitas
  • Romania · Imakrebin, Imatinib Grindeks
  • Sweden · Bimatix, Imatinib Amarox
  • Slovenia · Meaxin
  • Slovakia · Imatinib Glenmark, Imatinib Grindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed53147c-ca91-476f-9b46-9198e1510a79
GET /v1/drugs/ed53147c-ca91-476f-9b46-9198e1510a79?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01X"
  ],
  "strength": null,
  "pa_number": "EU/1/13/845/009-014",
  "substances": [
    "Imatinib mesilate"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "01/07/2013",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0171-068-009"
}
API referenceMCP serverPlans

See everything about imatinib mesilate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console